Related Experiment Videos

Metabolism of polycyclic aza-aromatic carcinogens catalyzed by four expressed human cytochromes P450

S J Roberts-Thomson1, M E McManus, R H Tukey

  • 1Department of Pharmacy, University of Sydney, New South Wales, Australia.

Cancer Research
|March 1, 1995
PubMed

Insights

Human cytochromes P4501A2 and P4503A4 play key roles in metabolizing polycyclic aza-aromatic hydrocarbons, influencing toxicant activation and detoxification pathways. Understanding these P450 enzyme specificities is crucial for assessing individual risk from environmental pollutants.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Polycyclic aza-aromatic hydrocarbons (PAHs) are environmental toxicants.
  • Human cytochromes P450 (CYPs) are crucial for metabolizing xenobiotics.
  • CYP1A and CYP3A subfamilies are involved in PAH metabolism.

Purpose of the Study:

  • Investigate the role of human CYPs 1A1, 1A2, 3A4, and 3A5 in metabolizing 7-methylbenz(c)acridine and dibenz(aj)acridine.
  • Determine regioselectivity and stereoselectivity of PAH metabolism by specific CYPs.
  • Examine metabolite distributions with enzyme inhibitors and modulators.

Main Methods:

  • Incubation of PAHs with human liver microsomes expressing specific CYPs.
  • Analysis of metabolites using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).
  • Use of epoxide hydrolase inhibitor and CYP modulator to study metabolic pathways.

Main Results:

  • CYP1A2 showed high regioselectivity for proximate carcinogen formation from 7-methylbenz(c)acridine.
  • CYP3A4 was most regioselective for K-region oxidation of 7-methylbenz(c)acridine.
  • Dibenz(aj)acridine metabolism showed different regioselectivity patterns depending on the CYP involved.
  • Stereochemical analysis revealed specific configurations for dihydrodiol and epoxide metabolites, with some CYP-dependent stereoselectivity.

Conclusions:

  • CYP isoforms exhibit distinct regioselectivity and stereoselectivity in PAH metabolism.
  • Metabolite profiles and stereochemistry are influenced by the specific CYP enzyme involved.
  • Individual variations in CYP expression levels can significantly impact the activation and detoxification of PAHs, affecting toxicological outcomes.

Related Concept Videos